-
1 Comment
OptimizeRx Corporation is currently in a long term uptrend where the price is trading 35.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.3.
OptimizeRx Corporation's total revenue rose by 122.6% to $16M since the same quarter in the previous year.
Its net income has increased by 168.4% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 31.9% to $-3M since the same quarter in the previous year.
Based on the above factors, OptimizeRx Corporation gets an overall score of 4/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US68401U2042 |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | 185M |
|---|---|
| Target Price | 10.8333 |
| Beta | 1.28 |
| PE Ratio | None |
| Dividend Yield | None |
OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OPRX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
